PHARMACEUTICALS: SPAPs That Want Preferred Drug Plans Out Of Luck

Article Overview

This article explains a CMS memorandum addressing whether state pharmacy assistance programs can direct low-income beneficiaries into preferred Medicare Part D prescription drug plans. It summarizes the agency’s position, the broader policy dispute with a federal transition commission, and the potential program and compliance implications for states and plan sponsors. The piece is relevant to readers following Medicare Part D administration, SPAP operations, and federal oversight of beneficiary enrollment practices.